Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article. Marijuana is a substance that has been used medically for thousands of years. Recent archeological evidence shows that in the …
Download this entire issue or browse individual articles by title below. Front Cover 1 President’s Review Rick Doblin, Ph.D. 2 FDA-Approved MDMA Protocol: Experimental Design and Methods 4 A Long-Term …
Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article. I belong to the generation of Czechoslovak psychiatrists who had access to LSD in the sixties. As Drs. Grof and Dytrich stated …
Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article. We began to use ketamine for alcoholism therapy in 1985. At that time, we did not know very much about psychedelic therapy. So …
Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article. This year has been a historic one for the Santo Daime doctrine. I returned from Brazil in July of this year where I attended the …
Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article. The Spring, 1992 issue of the MAPS newsletter discussed the controversy concerning sentencing guidelines for people convicted …
Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article. Why in the world would MAPS hire a patent attorney? After all, MDMA was patented in 1914 in Germany by the Merck Pharmaceutical …
Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article.
Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article. "Change", the mantra of President-elect Clinton, is revitalizing the field of psychedelic research. The first flickerings …
Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article. The Governer’s office of the State of Massachusetts has recently approved our application for access to the files of the …
Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article.
Winter 1992/93 Vol. 03, No. 4 Forging New Alliances Download this article. The National Institute on Drug Abuse (NIDA) has scored highly a grant proposal to continue the clinical research with hallucinogens …